Becotatug Vedotin Plus PD-1 Inhibitor for Head and Neck Squamous Cell Carcinoma
NCT07683507
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DRUG:
Becotatug Vedotin Combined with PD-1 Inhibitor
Sponsor
Feng Liu